Estrogen and progesterone receptor negative (ER−, PR−) and human epidermal growth factor receptor 2 negative (HER2−), that is, triple negative BrCa has higher incidence in premenopausal women compared to older women.9 The gene discussed is ERBB2; the disease is invasive breast carcinoma.